The "gut microbiota" hypothesis in primary sclerosing cholangitis.
作者信息
Pontecorvi Valerio, Carbone Marco, Invernizzi Pietro
机构信息
Program for Autoimmune Liver Diseases, International Center for Digestive Health, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
出版信息
Ann Transl Med. 2016 Dec;4(24):512. doi: 10.21037/atm.2016.12.43.
Abstract
摘要
相似文献
1
The "gut microbiota" hypothesis in primary sclerosing cholangitis.
Ann Transl Med. 2016 Dec;4(24):512. doi: 10.21037/atm.2016.12.43.
2
Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019.
Clin Res Hepatol Gastroenterol. 2020 Apr;44(2):123-125. doi: 10.1016/j.clinre.2019.06.005. Epub 2019 Jun 28.
3
Healthy Donor Fecal Microbiota Transplantation for Recurrent Bacterial Cholangitis in Primary Sclerosing Cholangitis - A Single Case Report.
J Clin Transl Hepatol. 2018 Dec 28;6(4):438-441. doi: 10.14218/JCTH.2018.00033. Epub 2018 Aug 1.
4
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis.
Liver Int. 2019 Feb;39(2):371-381. doi: 10.1111/liv.13979. Epub 2018 Oct 24.
5
The features of mucosa-associated microbiota in primary sclerosing cholangitis.
Aliment Pharmacol Ther. 2016 Apr;43(7):790-801. doi: 10.1111/apt.13552. Epub 2016 Feb 9.
6
Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.
Am J Gastroenterol. 2019 Jul;114(7):1027-1029. doi: 10.14309/ajg.0000000000000191.
7
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
Gut. 2019 Aug;68(8):1477-1492. doi: 10.1136/gutjnl-2018-316670. Epub 2019 Mar 14.
8
Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?
Aliment Pharmacol Ther. 2019 Sep;50(5):605-606. doi: 10.1111/apt.15424.
9
Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.
Aliment Pharmacol Ther. 2019 Sep;50(5):606-607. doi: 10.1111/apt.15434.
10
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.
引用本文的文献
1
Causal relationship between primary biliary cholangitis and inflammatory bowel disease: a Mendelian randomization study.
Gastroenterol Rep (Oxf). 2024 May 16;12:goae049. doi: 10.1093/gastro/goae049. eCollection 2024.
2
Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels.
ACG Case Rep J. 2024 Jan 16;11(1):e01256. doi: 10.14309/crj.0000000000001256. eCollection 2024 Jan.
3
Causal associations between inflammatory bowel disease and primary biliary cholangitis: a two-sample bidirectional Mendelian randomization study.
Sci Rep. 2023 Jul 6;13(1):10950. doi: 10.1038/s41598-023-35785-2.
4
Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention.
Adv Cancer Res. 2022;156:39-73. doi: 10.1016/bs.acr.2022.02.001. Epub 2022 Mar 10.
5
Autoimmune enteropathy and primary biliary cholangitis after proctocolectomy for ulcerative colitis: A case report and review of the literature.
World J Gastroenterol. 2021 Aug 7;27(29):4929-4938. doi: 10.3748/wjg.v27.i29.4929.
6
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis.
Cells. 2021 Jun 29;10(7):1622. doi: 10.3390/cells10071622.
7
The Potentiality of Herbal Remedies in Primary Sclerosing Cholangitis: From to Clinical Studies.
Front Pharmacol. 2020 Jun 10;11:813. doi: 10.3389/fphar.2020.00813. eCollection 2020.
本文引用的文献
1
Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
Gut. 2017 Jul;66(7):1344-1346. doi: 10.1136/gutjnl-2016-312533. Epub 2016 Sep 26.
2
Primary Sclerosing Cholangitis.
N Engl J Med. 2016 Sep 22;375(12):1161-70. doi: 10.1056/NEJMra1506330.
3
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
Gut. 2016 Oct;65(10):1681-9. doi: 10.1136/gutjnl-2015-311004. Epub 2016 May 20.
4
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Gut. 2017 Apr;66(4):611-619. doi: 10.1136/gutjnl-2015-310500. Epub 2016 Feb 17.
5
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.
Hepatology. 2016 Jan;63(1):185-96. doi: 10.1002/hep.27927. Epub 2015 Aug 10.
6
Differences in bile microbiology according to region and hospital: response to correspondence on "Bile microbiology at a hospital in southern Taiwan".
Infection. 2013 Oct;41(5):1037-8. doi: 10.1007/s15010-013-0416-0. Epub 2013 Feb 10.
7
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study.
Aliment Pharmacol Ther. 2013 Mar;37(6):604-12. doi: 10.1111/apt.12232. Epub 2013 Feb 5.
8
Perinatal programming of asthma: the role of gut microbiota.
Clin Dev Immunol. 2012;2012:932072. doi: 10.1155/2012/932072. Epub 2011 Nov 3.
9
Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy.
J Allergy Clin Immunol. 2011 Nov;128(5):948-55.e1-3. doi: 10.1016/j.jaci.2011.07.027. Epub 2011 Aug 27.
10
Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.
Gastroenterology. 2009 Jul;137(1):320-9. doi: 10.1053/j.gastro.2009.02.046. Epub 2009 Feb 21.
Zotero 插件